Cargando…

Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor

BACKGROUND: The cholecystokinin receptor subtype 2 (CCK-2R) is an important target for diagnostic imaging and targeted radionuclide therapy (TRNT) due to its overexpression in certain cancers (e.g., medullary thyroid carcinoma (MTC)), thus matching with a theranostic principle. Several peptide conju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lipiński, Piotr F. J., Garnuszek, Piotr, Maurin, Michał, Stoll, Raphael, Metzler-Nolte, Nils, Wodyński, Artur, Dobrowolski, Jan Cz., Dudek, Marta K., Orzełowska, Monika, Mikołajczak, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902437/ https://www.ncbi.nlm.nih.gov/pubmed/29663167 http://dx.doi.org/10.1186/s13550-018-0387-3

Ejemplares similares

From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial
por: Pawlak, Dariusz, et al.
Publicado: (2016)

Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of (177)Lu- and (90)Y-Rituximab in Xenografted Mice
por: Karczmarczyk, Urszula, et al.
Publicado: (2018)

Evaluation of Actinium-225 Labeled Minigastrin Analogue [(225)Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
por: Qin, Yun, et al.
Publicado: (2020)

Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples
por: Kolenc Peitl, Petra, et al.
Publicado: (2019)

Exploiting the Concept of Multivalency with (68)Ga- and (89)Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression
por: Summer, Dominik, et al.
Publicado: (2018)

The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
por: Duatti, Adriano
Publicado: (2023)

Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue
por: Pfister, Joachim, et al.
Publicado: (2015)

Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression
por: Summer, Dominik, et al.
Publicado: (2018)

Stabilization Strategies for Linear Minigastrin Analogues: Further Improvements via the Inclusion of Proline into the Peptide Sequence
por: Klingler, Maximilian, et al.
Publicado: (2020)

Oxidant and Antioxidant Effects of Gentisic Acid in a (177)Lu-Labelled  Methionine-Containing Minigastrin Analogue
por: Trindade, Victoria, et al.
Publicado: (2020)

Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
por: Opalinska, Marta, et al.
Publicado: (2023)

PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties
por: Garnuszek, Piotr, et al.
Publicado: (2021)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

On constitutional isomers and tautomers of oxadiazolones and their mono- and disulfur analogues (C(2)H(2)N(2)XY; X, Y = S, O)
por: Karpińska, Grażyna, et al.
Publicado: (2013)

Cholecystokinin (CCK) and its receptors (CCK1R and CCK2R) in chickens: functional analysis and tissue expression
por: Wan, Yiping, et al.
Publicado: (2022)

Structural Insights into σ(1) Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations
por: Kurciński, Mateusz, et al.
Publicado: (2018)

Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs
por: Holzleitner, Nadine, et al.
Publicado: (2023)

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma
por: Fröberg, Alida C., et al.
Publicado: (2009)

Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [(177)Lu]Lu-PP-F11N
por: Grzmil, Michal, et al.
Publicado: (2021)

Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo
por: Ashurst, H Louise, et al.
Publicado: (2008)

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors
por: Roosenburg, Susan, et al.
Publicado: (2010)

Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease
por: Lipiński, Piotr F.J., et al.
Publicado: (2021)

Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis
por: Lipiński, Piotr F. J., et al.
Publicado: (2019)

On Aromaticity of the Aromatic α-Amino Acids and Tuning of the NICS Indices to Find the Aromaticity Order
por: Dudek, Wojciech M., et al.
Publicado: (2022)

Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [(177)Lu]Lu-PP-F11N
por: Grzmil, Michal, et al.
Publicado: (2020)

Does the Number of Bifunctional Chelators Conjugated to a mAb Affect the Biological Activity of Its Radio-Labeled Counterpart? Discussion Using the Example of mAb against CD-20 Labeled with (90)Y or (177)Lu
por: Karczmarczyk, Urszula, et al.
Publicado: (2022)

Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs
por: Christoffersen, Berit Ø., et al.
Publicado: (2019)

Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs
por: Zavvar, Taraneh Sadat, et al.
Publicado: (2023)

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG Uptake in Esophageal Cancer
por: Liu, Huipan, et al.
Publicado: (2022)

Radiopharmaceutical Formulation and Preclinical Testing of (68)Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial
por: Hörmann, Anton A., et al.
Publicado: (2021)

CCK2 receptors in chronic pain
por: LaVigne, Justin E., et al.
Publicado: (2022)

CCK reduces the food intake mainly through CCK1R in Siberian sturgeon (Acipenser baerii Brandt)
por: Zhang, Xin, et al.
Publicado: (2017)

Substituent Effect in the Cation Radicals of Monosubstituted Benzenes
por: Dobrowolski, Jan Cz., et al.
Publicado: (2021)

Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin (177)Lu-PP-F11N
por: Grob, Nathalie M., et al.
Publicado: (2021)

A novel CCK(2)/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study
por: Erba, Paola A., et al.
Publicado: (2018)

Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patients
por: Maina, Theodosia, et al.
Publicado: (2016)

IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
por: Jalilian, Amir R., et al.
Publicado: (2022)

Clickable Radiocomplexes With Trivalent Radiometals for Cancer Theranostics: In vitro and in vivo Studies
por: D'Onofrio, Alice, et al.
Publicado: (2021)

Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals
por: von Guggenberg, Elisabeth, et al.
Publicado: (2021)

Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo
por: Holzleitner, Nadine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d47feqjrt9j8f8dgaop7n02se7